CRDF Files Lawsuit Against Nerviano Medical Sciences, Disputes Alleged Material Breach of Onvansertib License Agreement
Cardiff Oncology, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.90
+8.0% in 7d after detection
Post-detection moves
1h
—
1d
+4.5%
3d
+1.1%
7d
+8.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS